Table 1.
Characteristic | Distribution |
---|---|
Outcome | |
DF cases (%) | 31 (72.1%) |
non-DF cases (%) | 12 (27.9%) |
Gender | |
Male (%) | 21 (48.8%) |
Female (%) | 22 (51.2%) |
Tumor site | |
Trunk (%) | 20 (46.6%) |
Palms and (%) | 1 (2.3%) |
Extremities (abs.; %) | 11 (25.6%) |
Head & neck (%) | 1 (2.3%) |
Lymph nodes (%) | 5 (11.6%) |
Other (%) | 5 (11.6%) |
Stage | |
I (abs.; %) | 6 (14.0%) |
II (abs.; %) | 27 (62.7%) |
III (abs.; %) | 10 (23.3%) |
T | |
T0 (abs.; %) | 2 (4.7%) |
T1 (abs.; %) | 3 (6.8%) |
T2 (abs.; %) | 10 (23.3%) |
T3 (abs.; %) | 6 (14.0%) |
T4 (abs.; %) | 22 (51.2%) |
Age | |
Median (std.) | 64.0 (14.9) |
For categorical variables, percentage (%) counts are reported. For continuous values, the median and standard deviation (sd.) values are indicated.
The abbreviation DF stands for disease free. Among the five patients for which the tumor site has been labelled as ‘Other’, more detailed specifics about the tumor site were available online. For two of these patients, the primary site was specified to be unknown. The other three tumor sites were the left shoulder, the right shoulder and the IV toe of the left foot, respectively.